Role of positive peritoneal cytology in FIGO stage IB to IIB cervical adenocarcinoma
Ying Han(Fujian University of Traditional Chinese Medicine), Lingying Wu(Chang Gung University), Ning Li(Shenyang Pharmaceutical University), Xiaoguang Li(Beijing University of Technology), Rong Zhang(Columbia University Irving Medical Center), Yangchun Sun(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 2
Related Papers
In silico ADME and Toxicity Prediction of Ceftazidime and Its Impurities
|Frontiers in Pharmacology|2019|287
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212
Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
|PubMed|2003|198
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer
|JAMA Oncology|2023|165
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
|Journal for ImmunoTherapy of Cancer|2020|153